News and Events

Cellomatics BioSciences Ltd will be moving to a new facility

119-122 Stewart Adams Building, Biocity, Pennyfoot Street, Nottingham NG1 1GF.

Extremely proud to announce that as of 1st Feb 2018, we will be moving to our new state-of-the-art facility at 119-122 Stewart Adams Building, Biocity, Pennyfoot Street, Nottingham NG1 1GF.

The new facility will accommodate the growing business and provide needed additional space for the company’s diversified portfolio of preclinical in vitro services. 

Incorporated in 2015, Cellomatics BioSciences is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. We provide bespoke pre-clinical/early discovery phase laboratory services to support pharmaceutical, biotechnology companies and academic groups in their drug development programmes.

This exciting move is backed by the significant growth experienced by the company over the last year. As we expand our team and the portfolio of services that we offer, we realised that moving to a larger facility is a necessary step to accommodate our customers and market needs. We intend to continue adding new services, as well as building a great team that can support our plans and further growth going forward.

I would like to take this opportunity to express my gratitude to our sponsors/clients for their continued faith in our capabilities. We will continue to provide premier services to all our customers with a simple work philosophy of conducting ethical and high quality scientific research.  Last but not least, extremely thankful to my team of scientists and business development personnel for their outstanding work and contributions to this achievement.

As we step into the New Year, I am extremely proud to announce that as of 1st Feb 2018, Cellomatics BioSciences Ltd will be moving to our new state-of-the-art facility at 119-122 Stewart Adams Building, Biocity, Pennyfoot Street, Nottingham NG1 1GF.

The new facility will accommodate the growing business and provide needed additional space for the company’s diversified portfolio of preclinical in vitro services.

Incorporated in 2015, Cellomatics BioSciences is a laboratory-based Contract Research Organisation (CRO) providing bespoke pre-clinical laboratory services to support drug development programmes.

This exciting move is backed by the significant growth experienced by the company over the last year. As we expand our team and the portfolio of services that we offer, we realised that moving to a larger facility is a necessary step to accommodate our customers and market needs.

I would like to take this opportunity to express my gratitude to our sponsors/clients for their continued faith in our capabilities. Last but not least, extremely thankful to my team for their outstanding work and contributions to this achievement. We will continue to provide premier services to all our customers with a simple work philosophy of being an honest and an aspirational CRO.